- Clinical trials are research studies that test whether a treatment is safe and works; they are not guaranteed therapy.
- Fatty liver disease (NAFLD/NASH, now often called MASLD/MASH) is an active area of research with many ongoing trials.
- Trials move through phases (1 through 4) that test safety, dosing, and effectiveness in increasing numbers of people.
- Informed consent means you can ask questions and leave a study at any time.
- ClinicalTrials.gov is a public registry where you can search for studies; discuss any trial with your own doctor first.
- Never stop your current care or treatment to join a study without talking to your clinician.
Fatty liver disease — the buildup of fat in the liver not caused mainly by alcohol — is one of the most active areas of medical research today. You may see it called nonalcoholic fatty liver disease (NAFLD) or its more advanced form, nonalcoholic steatohepatitis (NASH); newer terminology from medical societies uses MASLD and MASH. Because there are still limited approved medications, many people ask whether joining a clinical trial is an option. This guide explains what fatty liver clinical trials are, how they work, and how to think about them. It is educational only and is not medical advice.
What a clinical trial actually is
A clinical trial is a research study that tests whether a new treatment — a medication, a device, a diet, or a lifestyle program — is safe and how well it works in people. According to the NIH and MedlinePlus, trials follow a carefully written plan called a protocol, and they are reviewed by an independent ethics board (often called an IRB, or institutional review board) before enrolling anyone.
The most important idea to hold onto: research is not the same as guaranteed treatment. A study exists precisely because the answer is not yet known. You might receive a promising new therapy, a standard treatment, or a placebo, and the treatment being studied may turn out to help, do nothing, or cause side effects. Joining a trial is a contribution to knowledge that may or may not benefit you directly.
The phases of a clinical trial
Trials are usually described in phases, each answering a different question. The NIDDK and ClinicalTrials.gov describe them roughly as follows:
| Phase | Main question | Typical size |
|---|---|---|
| Phase 1 | Is it safe? What dose can people tolerate? | Small (often tens of people) |
| Phase 2 | Does it seem to work, and what are the side effects? | Moderate (often up to a few hundred) |
| Phase 3 | Does it work better than existing options, in a larger group? | Large (hundreds to thousands) |
| Phase 4 | What are the long-term and real-world effects after approval? | Very large, post-approval |
For fatty liver disease specifically, researchers are studying medications aimed at reducing liver fat, inflammation, and scarring (fibrosis), as well as lifestyle and weight-management approaches. Because NASH/MASH can progress slowly, many trials also track blood markers and liver imaging over time; some use liver biopsy to measure change.
Informed consent and your rights
Before you can join any trial, the research team must go through informed consent. This is a process — not just a signature — in which the team explains the study’s purpose, what will happen, the possible risks and benefits, and your alternatives. Under NIH and Office for Human Research Protections guidance, you have the right to ask questions, take the paperwork home, and decide freely. Critically, you can withdraw from a study at any time, for any reason, without losing your regular medical care.
Good questions to ask include: What is being tested and why? What are the possible side effects? Will I know whether I am getting the active treatment? Who pays for study-related care and any costs? What happens to my regular treatment during the study? How long is the commitment, and how many visits are involved?
How to find fatty liver trials
The main public resource is ClinicalTrials.gov, a registry run by the U.S. National Institutes of Health that lists studies taking place in the United States and around the world. You can search by condition (for example, “NAFLD,” “NASH,” “MASLD,” or “fatty liver”), by location, and by recruitment status. Each listing describes who can join (eligibility criteria), where the study is running, and how to contact the research team.
Eligibility rules exist to keep participants safe and to answer the research question clearly, so not everyone who applies will qualify. Your own doctor — or a liver specialist (hepatologist) — can help you understand whether a study is a reasonable fit and whether the timing makes sense given your overall health. Many people learn about trials through the specialists already managing their fatty liver, alongside routine monitoring such as liver enzyme panels and inflammation blood tests.
Weighing the decision
There is no single right answer. Some people value early access to investigational therapies and close monitoring; others prefer to wait for approved options. Whatever you decide, the golden rule is: do not stop your current treatment or care to join a study without talking to your clinician first. Fatty liver management often involves managing weight, blood sugar, cholesterol, and other conditions, and abruptly changing that plan can cause harm. A trial should fit into your care, not replace it unsupervised.
Frequently asked questions
Are clinical trials safe?
Trials are designed with safety monitoring and ethics review, but no research is risk-free. That is why informed consent explains potential harms and why you are watched closely during a study. Ask the team about the specific risks of the trial you are considering.
Will I definitely get the new treatment?
Not necessarily. Many trials compare a new treatment against a placebo or standard care, and assignment is often random. You may not know which group you are in until the study ends.
Does it cost money to join a trial?
It varies. Some study-related care is provided at no cost, while other costs may fall to you or your insurance. Always ask about costs, travel, and what is covered before enrolling.
Can I leave a trial once I start?
Yes. You can withdraw at any time, for any reason, and your regular medical care should continue. This right is a core part of informed consent.
Is a clinical trial my only option for fatty liver?
No. Lifestyle changes, managing related conditions, and any approved treatments your doctor recommends are the foundation of care. A trial is one possible addition to discuss, not a replacement for standard management.
Where should I start?
Start with your own clinician and, if relevant, a search on ClinicalTrials.gov. You can also read our wellness guide hub and related explainers such as the hepatitis panel, since liver testing often comes up together with fatty liver care.
This article is for general education and is not medical advice. Clinical trials involve uncertainty and possible risks, and eligibility and outcomes vary from person to person. Talk to your doctor or a liver specialist before considering any study, and never stop your current care to join a trial without professional guidance.
Sources
- ClinicalTrials.gov (U.S. National Institutes of Health) — Study registry, phases, and eligibility
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) — NAFLD/NASH information
- MedlinePlus (U.S. National Library of Medicine) — Clinical trials and informed consent
- NIH / Office for Human Research Protections — Informed-consent and participant-rights guidance